Union Health Minister launches Sixth Edition of National Formulary of India
NFI has been published by the Indian Pharmacopoeia Commission to promote the rational use of medicines in the country
Union Minister for Health and Family Welfare Dr Mansukh Mandaviya launched the Sixth Edition of the National Formulary of India (NFI). NFI has been published by the Indian Pharmacopoeia Commission (IPC) to promote the rational use of medicines in the country.
Speaking at the event, Dr Mandaviya congratulated IPC for coming up with the new edition of NFI. He appreciated the efforts of all the experts, doctors and researchers who contributed to the compilation of the new edition. He said that NFI, 2021 would act as a guidance document for all the healthcare professionals such as clinicians, pharmacists, nurses, dentists etc. It will play a crucial role in daily clinical practices.
He said that medicines behave differently in different bodies. It is important to know about the content, impact and side effects of medicines. The NFI is published to promote the rational use of medicines in the country. It will be very beneficial for Clinicians and Healthcare professionals while prescribing the medicines to the patients.
The 6th Edition of NFI 2021 has been drafted by adopting the principle ‘do not miss critical and do not overload’ the information by revising the appendices, chapters and drug monographs. The chapters such as analgesics, antipyretics and anti-inflammatory drugs, antiepileptics, antacids and antiulcer drugs, antiallergics and drugs used in anaphylaxis, antidiarrhoeals and laxatives, antidotes and substances used in poisoning, antimigraine drugs, basics of medical emergencies, dermatological drugs, disease-modifying anti-rheumatic drugs (DMARDs) and drugs for gout, diuretics, drugs in osteoporosis, drugs for inflammatory bowel disease, drugs for respiratory diseases, ophthalmological preparations and psychotherapeutics drugs were revised thoroughly by involving the subject-specific experts/specialist in the country.
PIB
